Inflammation and Immunology Research Unit, Pfizer, Cambridge, Massachusetts.
These authors contributed equally to this work.
Curr Protoc. 2024 May;4(5):e1026. doi: 10.1002/cpz1.1026.
Nuclear factor-κB (NF-κB) is a crucial pro-inflammatory transcription factor whose activation is of immense interest to immunology research. Estimation of NF-κB activation through flow cytometry is not possible due to the unavailability of robust flow cytometry antibodies that can bind to its phosphorylated, active, nuclear form. In this protocol, we describe a flow cytometry assay that measures the activation of the pro-inflammatory transcription factor NF-κB in stimulated immune cells by quantifying the degradation of its upstream regulator IκBα. We demonstrate the utility of this protocol by assessment of intracellular IκBα in human primary regulatory T cells experiencing TNFR2 agonism, a process previously reported to activate NF-κB in these cells. We also show that this assay may be applied to study NF-κB activation in other cell types, such as human primary T cells and THP-1 cell-derived macrophages, when induced by their corresponding inflammatory cues. Thus, this robust and reproducible protocol will be of interest to a wide range of scientists who aim to measure NF-κB activity in medium-to-high-throughput assays. © 2024 Wiley Periodicals LLC. Basic Protocol: Quantifying inflammatory activation by flow cytometry of IκBα degradation Support Protocol 1: Isolating and expanding human regulatory T cells Support Protocol 2: Calculating IC from flow cytometry data using Excel.
核因子-κB(NF-κB)是一种关键的促炎转录因子,其激活对免疫学研究具有重要意义。由于缺乏能够与磷酸化、活性核形式结合的稳健流式细胞术抗体,因此无法通过流式细胞术估计 NF-κB 的激活。在本方案中,我们描述了一种流式细胞术测定法,通过定量其上游调节剂 IκBα 的降解来测量刺激免疫细胞中促炎转录因子 NF-κB 的激活。我们通过评估经历 TNFR2 激动剂的人原代调节性 T 细胞中细胞内 IκBα来证明该方案的实用性,据报道,该过程可激活这些细胞中的 NF-κB。我们还表明,当通过相应的炎症信号诱导时,该测定法可应用于研究其他细胞类型(如人原代 T 细胞和 THP-1 细胞衍生的巨噬细胞)中的 NF-κB 激活。因此,这种稳健且可重复的方案将引起旨在测量中高通量测定中 NF-κB 活性的广泛科学家的兴趣。©2024Wiley Periodicals LLC。基本方案:通过 IκBα 降解的流式细胞术定量炎症激活支持方案 1:分离和扩增人调节性 T 细胞支持方案 2:使用 Excel 从流式细胞术数据中计算 IC。